Form 8-K - Current report:
SEC Accession No. 0001437749-17-016076
Filing Date
2017-09-19
Accepted
2017-09-19 16:48:56
Documents
1
Period of Report
2017-09-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20170915_8k.htm 8-K 24053
  Complete submission text file 0001437749-17-016076.txt   25250
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 171092426
SIC: 2834 Pharmaceutical Preparations